The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) osimertinib is the current standard first-line therapy for patients with metastatic non–small cell lung cancer (NSCLC) ...

Externally small, with a pleasing form, internally very powerful with the features of high-level ultrasound scanners. Powerful and easy to use, IMAGYNE offers an exceptional image quality.